Recent News and Webcasts:
- Inhibitex to Host Conference Call to Report Second Quarter 2007 Financial Results on August 9, 2007
- Inhibitex, Inc. at 2007 FBR Growth Conference
- Inhibitex to Present at the FBR 2007 Growth Conference
Welcome to Inhibitex.com
Inhibitex is a clinical-stage biopharmaceutical
company dedicated
to the development of innovative products that can treat
or prevent serious infections. We are applying our expertise
in the development of anti-infectives to advance a broad
portfolio of antiviral and antibody-based therapies,
each of which has the potential to significantly improve
the standard of care. Our diverse pipeline addresses
major viral and bacterial infections, including herpes
zoster, HIV, HCV, CMV and S. aureus infections.
